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Abstract 
 
Background: Heme oxygenase-1 (HO-1) is a protein secreted by immune cells as a part of immune response 
mechanism.HO-1 can be induced by variety agents that causingoxidative stress, such as exposure to 100% oxygenat2,4 
ATA pressure.It plays a vital role in maintaining cellular homeostasis.This study was conducted to identify the effect of 
hyperbaric oxygen exposure in cultured ofPBMCthat infected by HIV-1. 
Material and Methods: Primary culture of PBMCs were isolated from 16 healthy volunteers and HIV-1 infected MT4 
cell line by co-culture. The PBMCs were aliquoted into two wells as control group and treatment group. The 16 
samples of HIV-1 infected PBMCwere exposed to oxygen at 2,4 ATA in animal hyperbaric chamber forthree times in 
30 minutes periods with 5 minutes spacing period, that called 1 session. 
The Treatment  done on 5 sessions within 5 days. 16 samples of HIV-1 infected PMBCs that have no hyperbaric 
treatment became control group.The supernatant were measured the HO-1 production by ELISA andmRNA expression 
of HO-1 by real time PCR and the number ofantigen p24 HIV-1by ELISA. 
Results: The result showed that there was no increasing of HO-1 at both mRNA level and protein level, there was a 
decreasing number of antigen p24 HIV-1 at the treatment group. In addition, hyperbaric exposure could not increase 
the expression of HO-1, more over the viral replication might be reduced by other mechanism.  
Conclusions: Hyperbaric oxygen could increases cellular adaptive response of PBMCs infected HIV-1 through 
increased expression of proteins that can inhibit HIV viralreplication. 
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Introduction 
 
Hyperbaric oxygen (HBO) therapy is exposure of pure oxygen at the pressure more than 1 ATA. During 
therapy, the haemoglobin reaches 100% saturation and more oxygen is dissolved in the plasma than usual, and high 
amount of oxygen is delivered to almost all tissues, enhancing blood and tissue oxygenation (Simsek et al., 2011). 
Exposure to pure oxygen in HBO therapy with therapeutic doses can increase oxidation products and the 
effectiveness of antioxidant defence mechanisms to prevent oxidative stress. Increased production of the superoxide 
radical followed by hydrogen peroxide will impactthe transcription factors with their main target protein heme 
oxigenase-1 (Simsek et al., 2015).Heme oxygenase-1 (HO-1) was increase 24 hours after hyperbaric oxygen exposure 
suggesting an involvement of HO-1 in the adaptive protection (Speit and Bonzheim, 2003). Heme oxygenase-1 is a 
protein which is highly inducible by a variety of agents causing oxidative stress and play a vital function in maintaining 
cellular homeostasis along with increase resistance against oxidant mediated cell injury. HO-1 involved in the adaptive 
protection against the induction of DNA damage after HBO treatment (Rothfuss et al., 2001). 
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The previous study reported the role of HO-1 in monocytes against HIV infection, showed that HO-1 
suppresses HIV-1 replication in primary human monocytes by PKC-dependent HO-1induction (Devadas et al., 2010). 
The other study showed that there was a strong evidence forHO-1 as a novel endogenous biologic component with anti 
HIV activity (Devadas and Dhawan, 2006).The aim of this study was to identify the effect of HBO whether HO-1 
produced after hyperbaric oxygen exposure could inhibit the HIV-1 replication. 
 
Materials and Methods 
Design Experiment 
 
This study was approved by the Institutional Ethics Committees of Medical Faculty Airlangga University 
Surabaya, Indonesia. Informed consent was obtained from all volunteers prior to sample collection. We recruited 
sample from healthy volunteers purposively with criteria as follows, aged about 18-23 years old, not suffering from 
chronic illness, not taking drugs such as steroids, cytostatic and drugs and not smoking. Eight milliliters of whole blood 
were obtained from each 16 healthy volunteers who had approved informed consent.This Peripheral Blood 
Mononuclear Cells (PBMCs) were further isolated and divided into two groups; treatment group (with HBO) and 
control group (no HBO). 
 
Isolation and Preparation of PHA-stimulated uninfected volunteer Peripheral Blood Mononuclear Cells 
(PBMCs) 
 
PBMCs were separated from whole blood freshly collected by using histopaque (SIGMA) density gradient 
centrifugation prepared frombuffy coat. PBMCs were re-suspended in RPMI 1640 (Gibco) medium supplemented with 
10%heat inactivated fetal bovine serum (FBS), 2mM L-glutamine, 100 μg/ml streptomycin, 10% purified human IL-2 
(SIGMA) and10 μg/ml PHA (SIGMA).The number of variable cells were counted by usingtrypan blue and 
hemocytometer. Viable cells looks clear, while the necrosis cells (nonviable cells) was blue. PBMCs were aliquoted 
into two wells of sterile 24 wells plate at concentration 5 x 10
5
 cell/µl, one well for control group and one well for 
treatment group. The uninfected PBMCs were cultured in medium with stimulated phytohemagglutinin (PHA, 10 
µg/mL) and incubated for three days in CO2 incubator. After three days, the culture fluid was incubated in RPMI-1640 
medium containing T cell growth factor cytokine IL-2 for three days in CO2 incubator, to reach the cell concentration 
of PBMC up to 1x10
6
 cell/µl.  
 
Infection with HIV-1 
 
Primary PBMCs culture fluid were infected with HIV-1 by co-cultured withHIV-1 MT4cell linein BSL-3 (Bio 
Safety Level 3) laboratory, Institute of Tropical Diseases (ITD) Universitas Airlangga, Surabaya, Indonesia. HIV-
infected PBMCs cultures were experimental units in this study. A total of 32 PBMCs infected cultures consist of 16 
samples treatment group (with HBO) and 16 samples control group (non HBO). 
 
Exposure to HBO 
 
The treatment group receivedHBO exposure. HBO exposure was performed in a hyperbaric animal chamber 
with temperature controlled (37
o
C).The experiment were conducted 3 times for 30 minutes, at 2,4 ATA and O2 100% 
and did intermission in 5 minutes with O2 21%. HBO exposure was performed at second day post HIV-1 inoculation for 
5 days. However the control group did not receive hyperbaric oxygen exposure. After the last HBO exposure, the 
examination was performed on both treatment group and control group, supernatant that was containing virus were 
harvested by centrifugation 1500 rpm for 5 min,and were stored at -80 
o
C for examination. The supernatant was 
measured for the concentration of HO-1 by ELISA and mRNA expression by qPCR. 
 
Quantitative analysis of HIV-1 replication 
 
The supernatant were assayed for HIV p-24 used ELISA analysis kit (RETROtex, Zeptometrix corporation 
buffalo, NY) according to the manufacturer instructions.Supernatant were collected to determine viral production level 
with measurement of HIV-1 p24 antigen.The level of captured p24 was determined by measuring the absorbance in 
wave length 450 nm using spectrophotometer. 
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Quantitative analysis of HO-1 protein and detection of mRNA HO-1expression by ELISA and real time PCR 
(qPCR) 
 
The supernatant were assayed for HO-1 using ELISA kit (R&D systems) and the examination levelsof HO-1 
was performed according to the procedures contained on the ELISA kit.To see whether the expression of HO-1 at the 
gene level is different from the expression at the protein level, we performed the examination by using   2 methods, 
measured the HO-1 protein by ELISA and measured the expression of the gene that encoding this protein by qPCR. 
RNA were extracted from cell culture using the QIA-amp RNA Mini kit (Qiagen,Hilden, Germany).RNA was 
reversedinto cDNA using the SuperScript III First-StandSynthesis kit (Invitrogen, Carlsbad, CA). The ssDNA 
concentration was determined by using Nano Drop spectrophotometer. While cDNA generation used  a reverse 
transcriptase kit,qPCR was performed using SsoFast
TM
 EvaGreen supermix (Bio Rad) with the primer 
sets.qPCRreaction was carried in a 10 µl reaction mixture containing 5 µl SsoFast
TM
 EvaGreen supermix (Bio Rad), 1 
µl each primer, 2 µltemplate and 1µl nuclease free water.HO-1 gene were amplified by PCR using the following primer 
pairs (sense 5’-CCT GCT CAA CAT CCA GCT C-3’,antisense 5’CTA CAG CAA CTG TCG CCA C- 3’).mRNA 
levels were expressed in relative copy number normalised against  GADPH mRNA.This normalisation against the 
housekeeping gene is possible if both PCR (HO-1 gene +housekeeping gene) present in the same efficiency.  
All data are expressed as the mean value and its standard deviation. Kolmogorov smirnov to analyse the 
distribution, followed by dependent test to analyse statistic (α=0.05). 
 
Results 
Level Heme Oxygenase-1 (HO-1) after hyperbaric oxygen treatment on PBMCs cultureinfected by HIV-1 
 
This study was performed on 32 samples of PBMC cell cultures infected with theHIV-1 MT4 virus, which is 
divided into 16 samples with hyperbaric oxygen treatment and16 samples as the control group. The number of cells in 
healthy PBMCs cultured wascalculated until 1 x 10
6
 cells/μl and the number of HIV-1 MT4 cell line was 1 x 106 
cells/μl too. The number of cells both in treatment and control group were homogeneous. The result showed that the 
treatment group concentrations of heme oxygenase-1 protein were slightly higher compared to the control group 
(Figure 1). Mean on treatment group was 1.38 ng/ml, and on control group was 0.89μg/ml. Heme oxygenase-1 
measurement was conducted 24 hours after the last of the hyperbaric oxygen exposure. 
 
 
Figure 1: Concentration of HO-1 protein 
  
Expression of Heme oxygenase-1 gene by quantitative RT-PCR obtained the following results as showed in 
Figure 2. 
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Figure 2: The mRNA expression activity of the gene encoding heme oxygenase-1 after HBO exposure 
  
 
Table 1: Difference value between HO-1 and mRNA expression qPCR 
Group of treatment 
HO-1 (ng/ml) HO-1 mRNA (fold) 
Mean SD Mean SD 
HBO Treatment 1.38 2.04 30,980 1,40 
No HBO Treatment 0.99 0.15 28,526 1,32 
 P= 0,600  P= 0,056  
 
At the protein level, using the WilcoxonSum Rank test showed a significance level of p = 0.600 (p>α), which 
means there was no difference in the levels of this protein in the treatment and control groups.Although the average 
levels of HO-1 was higher in the treatment group comparedwith the control group, there was nodifference in protein 
levels of heme oxygenase-1 after exposure to hyperbaric oxygen between treatment group and  control group (Table 1). 
At gene expression level, Wilcoxon Sum Rank test results showed p = 0.056 (p>α). Means that therewere no 
significant differences in mRNA levels HO-1 between treatment group and control group. 
 
The number of virus with the HIV-1 p24 antigen 
 
The number of virus was measured byassessing levels of HIV-1 p24 antigen. The results showed the levels of 
HIV-1 p24 antigen in thetreatment group was less than in the control group. 
 
 
Figure 3: The average amount of HIV-1 p24 antigen (ELISA) between treatment and control group 
 
Different test using WilcoxonSum Ranktest showed the results of p = 0.039 (p <α), which means that there 
was asignificant difference in the amount of p24 antigen levels of HIV-1 between treatment group and control group. 
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Discussion 
Analysis of the expression of mRNA and protein levels of the enzyme hemeoxygenase-1 
 
Compared with the control group, the levels of heme oxygenase-1 protein was higher in the treatment group, 
evenstatisticallythere was no significant difference. However, the gene expression of heme oxygenase-1 there were no 
significant difference expression between treatment group and  control group.HO-1 protein is a protein on group of heat 
shock protein that serve as protectiveprotein in cell mechanisms against stressor. The exposure of HBO on cell will 
impact on production of free radical that induce the expression of HO-1 gene. 
In this study, the level of HO-1 protein  was not increase, there was a transcriptional regulatory that affect the 
expression of protein HO-1 incell. In samples, with hyperbaric oxygen treatment, sources of oxidants derivedfrom viral 
replication and hyperbaric oxygen. On the other hand, withouthyperbaric oxygen, the oxidant source only derived from 
viral replication.Treatment control Hemeoxygenase protein, also known as heat shock protein (Hsp) 32 , were regulator 
of transcription factors by cell under stress conditions such ashypoxia, exposure to cytotoxic and hyperthermia (Abdalla 
et al., 2004), and also by free radical (Gill et al., 2015).The suppression of HO-1 protein levels was identified in 
cultured macrophagesfrom human brain tissue infected by HIV-1.The decreased in the expression of this enzymes in 
the macrophage cells was associated with increased oxidativestress due to viral replication and enhancement of 
glutamate as a result of injury tonerve tissue (Gill et al., 2015).The increase oxidants level in cells due to ongoing viral 
replication and the presence of reactive molecules of oxygen species (ROS) as a result of exposure to hyperbaric 
oxygen. 
The results showed that this studywas not consistent with the proposed research by Devadas and Dhawan, in 
2010, that there was existence barriers HIV-1 virus replication by heme oxygenase-1. However HO-1from their studies 
didnot come fromexposure to OHB but was induced by administration of hemin or lipopolysaccharide in the cultured 
of monocytes.It can be explained that in the treatment group, the levels of ROS ishigher than the control group as it 
gets exposure to ROS derived from HIV-1 viralreplication as well as from exposure to OHB, whereas in the control 
group ROSmolecules derived only from virus replication. However, the average levels of heme oxygenase-1 was 
higher in the treatment group. This suggests that exposureto OHB was able to induce heme oxygenase-1 as a response 
mechanism that actsas a cell adaptive anti-oxidants than as an antiviral. 
 
Analysis the number of antigen p24 HIV-1 
 
The result showed that the treatment group had a number of viruses that weresignificantly lower than the 
control group. Biomolecular effects of hyperbaric oxygen exposure at therapeutic dose through increasing ROS 
molecules will activate NFκB as transcription factors which were caused the expression of genes that produce proteins 
were required in the cell adaptive response.In this condition, HO-1 acts more as an antioxidant than antiviral. The 
antigen test is a valid measurement to measure productivity of infection. The concentration of HIV-1 p24 antigens in 
the culture supernatant fluids can be observed after the 5
th
 day of viral infection (Yang et al., 2013). 
 
Conclusion 
 
Exposure with hyperbaric oxygen at 2.4 ATA and 100% oxygen for 3x30 minutesfor 5 day in cultured of 
PBMCs infected HIV-1, was increased theadaptive response of cells by significantly decreased the number of 
antigenp24 HIV-1, but not in increased the expression of heme oxygenase-1.The decreased number of HIV-1 p24 
antigen in the treatment group showedthat cellsadaptive response result from activation of thetranscription factor to 
produce innate antiviral and inhibit viral replication. 
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